Triclocarban

Absorption

A human exposure study in a small group of subjects demonstrated that a portion of the TCC present in bar soaps is absorbed through the skin and is excreted in urine as N-glucuronides .
Because they are produced and used in large quantities in various products, they are absorbed into the human body of the general population .
The absorption of triclocarban during a human pharmacokinetic study was estimated at 0.6% of the 70 + or - 15 mg of triclocarban in the soap used. The triclocarban-N-glucuronide urine concentration varied considerably among the study subjects, and continuous daily use of the soap led to steady-state levels of excretion .

Toxicity

Ld50 of 2100 mg/kg in mice .
There has been concern voiced over the endocrine effect of triclocarban ande, in particular, on estrogen , ,,.
One study determined that triclocarban by itself stimulates AroB (brain aromatase) gene expression only slightly, but TCC strongly enhances the overexpression of AroB that is induced by exogenous estrogen. TCC has the potential to elevate levels of aromatase enzymes and, thereby, levels of endogenous estrogens in the developing brain . The effects of triclocarban on the endocrine system are presently not fully elucidated.

Description

Triclocarban, along with its cousin triclosan, is an antibacterial and antifungal component of personal care products such as soaps, toothpaste, and deodorants. It has been in use since the 1960s, but it has recently come under fire from the US Food and Drug Administration.
A rule proposed by the FDA in December 2013 would require manufacturers of antibacterial soaps and body washes to demonstrate that their products are safe for everyday use and are more effective than products without antibacterials. Proponents of the rule argue that users'' risk of bacterial infection is low; and therefore, the antibacterial additives are not needed. Producers rebut this argument by citing dozens of studies that show that antibacterial soaps significantly reduce bacteria levels on skin compared with ordinary soaps.
More recently, a bill in the New York State assembly would, if passed, ban the sale of antibacterial personal care products in that state.

The Uses of Triclocarban

Labelled Triclocarban

Indications

Triclocarban (TCC), or 3,4,4'-trichlorocarbanilide, is an antibacterial agent used in bar and liquid soaps and body washes .

Background

Triclocarban, with the chemical formula C13H9Cl3N2O is an antibacterial agent that is particularly effective against Gram-positive bacteria such as Staphylococcus aureus. It is a bacteriostatic compound that has been found in antibacterial soaps and other personal care products. In 2017, the US FDA prohibited the marketing of over-the-counter (OTC) consumer antiseptic wash products containing triclocarban due to negative health effects such as bacterial resistance or hormonal effects , .

What are the applications of Application

Triclocarban is an antiseptic and bacteriostat

Pharmacokinetics

The antimicrobial mechanism underlying the bacteriostatic and bactericidal effects of triclocarban is believed to be an unspecific adsorption to cell membranes and interruption of their function. As a result, the growth of gram-positive as well as gram-negative bacteria is inhibited .

Metabolism

Blood levels after parenteral injection are low and comparison of the radioactivity and chemical determinations suggest rapid metabolism of the Triclocarban .
Human metabolism of TCC involves direct glucuronidation to form N- and N'- glucuronides as well as ring hydroxylation to 2'-hydroxy-TCC and 6-hydroxy-TCC, which are further metabolized to sulfate and glucuronide conjugates. In human subjects given a single oral dose of TCC, 27% of the dose was excreted in the urine within 80 hours. About 70% of the administered dose was excreted in the feces within 5 days .
The major urinary metabolites were N-glucuronides (average levels, 30 ng/mL) and a major plasma metabolite was the sulfate conjugate of 2'-OH-TCC (levels ranged from 0-20 ng/mL .
The maximum plasma level occurred 2.8 hr after dosing and was 3.7 nmol-equivalents of TCC per g of plasma (approximately 1.2 ppm). Biotransformation of TCC was rapid but did not appear to involve splitting of the basic TCC structure. The major plasma metabolites were N- and N'-glucuronides of TCC which were eliminated with half-life approximately 2 hr to the urine and 2'-hydroxy-TCC sulfate and 6-hydroxy-TCC sulfate (the o-hydroxy-TCC sulfates) which were removed with half life approximately 20 hr (presumably into the bile) .